Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | MMP1 | P03956 | 1/20 | 0.61 |
| ▸ | MMP2 | P08253 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | MMP8 | P22894 | 1/20 | 0.61 |
| ▸ | MMP13 | P45452 | 1/20 | 0.61 |
| ▸ | F2 | P00734 | 3/20 | 0.56 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.56 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.56 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30446303 | 0.84 | KMT2A (1.00) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL2039879 | 0.84 | KMT2A (1.00) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL11566827 | 0.84 | KMT2A (1.00) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL2913624 | 0.81 | KMT2A (0.70) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL8402996 | 0.81 | KMT2A (0.70) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL1926677 | 0.81 | KMT2A (0.70) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL151052 | 0.81 | KMT2A (0.70) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL63933 | 0.81 | KMT2A (0.70) | KMT2AMEN1CA1CA2MMP1 | |
| Potassium Ion SCHEMBL7460752 | 0.81 | KMT2A (0.70) | KMT2AMEN1CA1CA2MMP1 | |
| SCHEMBL370668 | 0.81 | KMT2A (0.70) | KMT2AMEN1CA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2642 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024110994-A1 | A PROCESS FOR THE PREPARATION OF LEDIPASVIR | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2024-05-30 | — | — | WO | claimed |
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | claimed |
| EP-4306546-A1 | GLYCAN, AND METHOD FOR PRODUCING MEDICINE CONTAINING GLYCAN | Daiichi Sankyo Company, Limited (JP) | 2024-01-17 | — | — | EP | claimed |
| CN-116917341-A | Sugar chain and method for producing pharmaceutical product containing sugar chain | 第一三共株式会社 | 2023-10-20 | — | — | CN | claimed |
| WO-2023125896-A1 | GLP-1 AGONIST INTERMEDIATE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE | 海思科医药集团股份有限公司 | 2023-07-06 | — | — | WO | claimed |
| EP-3841101-B1 | METHOD FOR PREPARING 2-[(3R)-3-METHYLMORPHOLIN-4-YL]-4-[1-METHYL-1H-PYRAZOL-5-YL)-8-(1H-PYRAZOL-5-YL)-1,7-NAPHTHYRIDINE | BAYER AG (DE) | 2023-05-03 | — | — | EP | claimed |
| US-20230057246-A1 | NOVEL PROCESSES FOR PREPARATION OF TEZACAFTOR | LAURUS LABS LIMITED (IN) | 2023-02-23 | — | — | US | claimed |
| CN-115650827-A | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115651043-A | Preparation method of anthracycline derivative | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| EP-4099991-A1 | NOVEL PROCESSES FOR PREPARATION OF TEZACAFTOR | Laurus Labs Limited (IN) | 2022-12-14 | — | — | EP | claimed |
| EP-0741705-A1 | 4-(2-(3-ARYLOXY-2-HYDROXYPROPYLAMINO ALKYLOXY)-5-NITROPHENYL)-1,4-DIHYDROPYRIDINES AS ANTIHYPERTENSIVE AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-13 | — | — | EP | claimed |
| WO-1996011183-A1 | N-(ORTHO-SUBSTITUTED BENZYLOXY)IMINE DERIVATIVES AND THEIR USE AS FUNGICIDES, ACARICIDES OR INSECTICIDES | NOVARTIS AG (CH) | 1996-04-18 | — | — | WO | claimed |
| US-5426183-A | Reacting 2'-deoxy-2(2)-(di)fluorocarbohydrate witha nucleobase in an inert solvent | ELI LILLY AND COMPANY (US) | 1995-06-20 | — | — | US | claimed |
| EP-0522176-A1 | DIHYDROPYRIDINE COMPOUNDS, AND PROCESS FOR THEIR PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-01-13 | — | — | EP | claimed |
| WO-1992013839-A1 | DIHYDROPYRIDINE COMPOUNDS, AND PROCESS FOR THEIR PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-08-20 | — | — | WO | claimed |
| EP-0431794-A2 | 3-Fluorosulfonyloxyceph-3-EM displacement process | Bristol-Myers Squibb Company (US) | 1991-06-12 | — | — | EP | claimed |
| US-4994568-A | Intermediates for 6-,1- and 2-substituted carbapenem antibiotics | MERCK & CO., INC. (US) | 1991-02-19 | — | — | US | claimed |
| US-4837307-A | [1,1'-biphenyl]compounds having a 2,2'-(alkyl)bridge and a 3-yl(substituted)methyl substituent | FMC CORPORATION (US) | 1989-06-06 | — | — | US | claimed |
| US-4668792-A | Intermediates to insecticidal [1,1'-biphenyl]-3-ylmethyl esters | FMC CORPORATION (US) | 1987-05-26 | — | — | US | claimed |
| US-4291047-A | Combating fungi with α-azolyl-β-hydroxy-ketones | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-22 | — | — | US | claimed |